While the role of CCND2 is still controversial in a different type of tumors, high-level expression of CCND2 was observed in testicular and ovarian tumors [33, 34], and aberrant promoter methylation status of CCND2 was shown in breast cancer tissues [35, 36]. Here, CCND2 is linked to breast carcinoma.